Oragenics (OGEN) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free OGEN Stock Alerts $1.07 +0.02 (+1.90%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineStockNews.com Initiates Coverage on Oragenics (NYSE:OGEN)americanbankingnews.com - May 2 at 2:16 AMOragenics, Inc. (OGEN) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com - April 27 at 9:16 AMOragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.comamericanbankingnews.com - April 24 at 2:30 AMOdyssey Health, Inc. (ODYY)finance.yahoo.com - April 20 at 8:36 PMOragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standardsbusinesswire.com - April 19 at 5:50 PMOragenics Incmoney.usnews.com - April 17 at 9:54 AMOragenics, Inc. (OGEN) Latest Stock News & Headlines - Yahoo Financeca.finance.yahoo.com - April 16 at 4:18 AMOragenics, Inc. Files 10K and Provides Company Updatefinance.yahoo.com - April 1 at 10:20 AMOragenics Appoints Kelly As Chief Medical Officermarkets.businessinsider.com - March 18 at 9:24 AM15 Highest Quality Probiotics For Gut Healthfinance.yahoo.com - March 17 at 10:42 AMOragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussionbusinesswire.com - March 5 at 7:45 AMOragenics Announces Closing of Public Offeringbusinesswire.com - March 1 at 4:04 PMOragenics announces public stock offeringuk.investing.com - March 1 at 12:50 AMWhy Is Oragenics (OGEN) Stock Down 45% Today?investorplace.com - February 28 at 8:29 AMOragenics Prices Public Offering Of 1.40 Mln Shares At $1.50/shr; Stock Plungesmarkets.businessinsider.com - February 27 at 10:11 PMOragenics Announces Pricing of Public Offeringbusinesswire.com - February 27 at 9:25 PMOragenics Shares Fall After Proposed Public Offeringmarketwatch.com - February 27 at 6:42 PMOragenics Announces Proposed Public Offeringbusinesswire.com - February 27 at 4:33 PMOragenics CEO Murphy Leaves, President Redmond Named Interim Replacementmarketwatch.com - February 12 at 5:34 PMOragenics, Inc. Announces Leadership Transitionfinance.yahoo.com - February 12 at 4:50 PMOragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreementfinance.yahoo.com - February 7 at 9:44 AMOragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussionfinance.yahoo.com - February 5 at 9:02 AMOragenics terminates ATM offering program; shares jumpmsn.com - January 23 at 6:51 PMOragenics Announces Termination of At-The-Market Offering Programfinance.yahoo.com - January 23 at 6:51 PMOGEN, RLMD and ATXI among mid-day moversseekingalpha.com - January 6 at 2:37 PMOragenics Completes Acquisition of Odyssey Health’s Neurological Assetsfinancialpost.com - January 2 at 8:04 AMOdyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.finanznachrichten.de - December 12 at 9:20 AMOragenics, Inc. (UAV.F)finance.yahoo.com - November 6 at 1:34 PMOragenics Issues Update to Shareholdersfinance.yahoo.com - November 2 at 10:15 AMOragenics Shares Rise 15% After Deal to Buy Some Odyssey Health Assetsmarketwatch.com - October 5 at 2:21 PMOragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidatefinance.yahoo.com - October 5 at 9:19 AMOragenics, AVITA Medical among healthcare moversmsn.com - October 2 at 1:46 PMStocks to Watch: Oragenics, Natuzzi, Syndax Pharmaceuticalsmarketwatch.com - September 29 at 8:31 PMOragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assetsfinance.yahoo.com - September 29 at 6:15 PMOragenics, Inc. Announces Private Placementfinance.yahoo.com - August 7 at 10:40 AMOragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDMfinance.yahoo.com - June 5 at 4:40 PMOragenics to Participate in the World Vaccine Congress Washingtonfinance.yahoo.com - March 29 at 1:49 PMOragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VREfinance.yahoo.com - March 14 at 10:37 AMOragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership Teamfinance.yahoo.com - March 8 at 11:50 AMOragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pactfinance.yahoo.com - March 1 at 2:38 PMOragenics Enters into an Exclusive Global License Agreement with Inspirevax to Develop Intranasal Covid Vaccine Candidatefinance.yahoo.com - March 1 at 9:37 AMOragenics, Inc. Regains Compliance with NYSE Americanfinancialpost.com - February 3 at 7:37 AMOragenics, Inc. Discloses One-for-Sixty Reverse Stock Splitfinance.yahoo.com - December 23 at 4:15 PMOragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidatefinance.yahoo.com - December 22 at 10:04 AMOragenics, Inc. Receives NYSE American Noticefinance.yahoo.com - December 20 at 6:16 PMOragenics, Inc. Announces New Chairfinancialpost.com - December 19 at 5:07 PMOragenics to Participate in the 2022 BioFlorida Annual Conferencefinance.yahoo.com - October 24 at 5:18 PMOral & Dental Probiotics Market Size & Shares by 2027 | Revenue, Cost Analysis, Gross Margins, Future Inv - Benzingabenzinga.com - September 30 at 12:58 AMOragenics Inc OGEN Stock Quotemorningstar.com - September 9 at 12:16 AMOGEN.P - Oragenics Inc | Stock Price & Latest News | Reutersreuters.com - September 7 at 9:37 PM Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. OGEN Media Mentions By Week OGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OGEN News Sentiment▼0.000.42▲Average Medical News Sentiment OGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OGEN Articles This Week▼10▲OGEN Articles Average Week Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NexImmune News Today Cingulate News Today Lipella Pharmaceuticals News Today China Pharma News Today Petros Pharmaceuticals News Today Exicure News Today Artelo Biosciences News Today Bright Minds Biosciences News Today Alzamend Neuro News Today Ensysce Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OGEN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
